| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2222.1995.TB01079.X |
| P698 | PubMed publication ID | 7553251 |
| P2093 | author name string | L Larsson | |
| B Dahlén | |||
| S E Dahlén | |||
| M Kumlin | |||
| F Stensvad | |||
| P433 | issue | 5 | |
| P304 | page(s) | 467-479 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans | |
| P478 | volume | 25 |
| Q36765980 | Assessment of airway inflammation with exhaled NO measurement. |
| Q28195999 | Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib |
| Q27010165 | Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity |
| Q73428200 | Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge |
| Q37058183 | Elevated levels of leukotriene C4 synthase mRNA distinguish a subpopulation of eosinophilic oesophagitis patients. |
| Q34720407 | Exercise-induced bronchospasm in the elite athlete |
| Q35532197 | Exposure of healthy volunteers to swine house dust increases formation of leukotrienes, prostaglandin D2, and bronchial responsiveness to methacholine |
| Q79321294 | High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma |
| Q47882940 | Immunoaffinity resin for purification of urinary leukotriene E4. |
| Q42554727 | Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction |
| Q41861535 | Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005 |
| Q37365472 | Leukotriene-E4 in human urine: Comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay |
| Q44196256 | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. |
| Q43150802 | Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP). |
| Q35536702 | Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma |
| Q34892917 | Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease |
| Q42025112 | Ratio of leukotriene e(4) to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction |
| Q35537297 | Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis |
| Q80059774 | Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma |
| Q35535061 | Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma |
| Q73135740 | Serum ECP and MPO, but not urinary LTE4, are associated with bronchial hyper-responsiveness |
| Q33705493 | The measurement of leukotrienes in human fluids |
| Q44066341 | Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status |
Search more.